Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Observational Research Collaboratory - Long-Term Outcomes (LTO) Study

NCT05394025 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05394025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05394025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Observational Research Collaboratory - Long-Term Outcomes (LTO) Study
Lead sponsor
VA Office of Research and Development
Phase
Observational
Overall status
Completed
Start date
May 18, 2022
Completion date
June 1, 2024
Enrollment
479 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection